Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New pap smear method could spot cervical cancer earlier in egyptian women

NCT ID NCT07250841

Diagnosis Sponsor: Kasr El Aini Hospital Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This study tested a liquid-based Pap smear (ThinPrep) to screen 984 Egyptian women aged 25–60 for early signs of cervical cancer during routine gynecology visits. The goal was to see if this method could detect abnormal cells more effectively than standard approaches. Results will show how many women had precancerous changes, helping improve early detection in general clinics.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Liquid-based Pap smear (ThinPrep)
What this could lead to
If successful, this could support wider use of liquid-based Pap smears for early cervical cancer detection in routine gynecology clinics.
What could go wrong
This is an observational study, not a treatment trial. It only measures detection rates, not whether screening reduces cancer deaths. Results may not apply outside Egypt.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

984 people

The number who actually took part.

Started

Sep 2024

Finished

Mar 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Women aged 25-60 attending Kasr Al-Aini outpatient gynecology clinics and undergoing routine cervical screening using liquid-based cytology.

Ages

25 to 60 years

Sex

Female participants only

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Females aged 25-60 * Attending Kasr Al-Aini outpatient gynecology clinics * Willing to provide informed consent Exclusion Criteria: * • Pregnancy * Prior hysterectomy * Existing cervical lesions * Previous CIN treatment in last 5 years

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cervical cancer (early detection) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

cervical cancer cervical intraepithelial neoplasia dysplasia of cervix Uterine Cervical Neoplasms

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Cervical cancer (early detection) Cervical intraepithelial neoplasia

Contacts and locations

Locations

  • Kasr Al-Aini Hospital - Cairo University

    Cairo, Egypt

More trials for these conditions

Other studies related to the condition(s) this trial covers.